Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GW Pharmaceuticals PLC (NASDAQ:GWPH)

115.06
Delayed Data
As of Dec 09
 -3.13 / -2.65%
Today’s Change
35.83
Today|||52-Week Range
137.88
+65.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues42.6M49.9M44.0M14.6M
 
 
 
 
 
Cost of Goods Sold448.0K1.1M3.9M3.8M
 
 
 
 
 
Depreciation And Amortization1.5M2.3M3.5M5.2M
 
 
 
 
 
 
Operating ExpensesGross Income40.6M46.5M36.6M5.6M
 
 
 
 
 
General Expenses57.0M84.4M133.5M164.1M
 
 
 
 
 
Research And Development51.0M72.2M114.1M141.1M
 
 
 
 
 
Total Operating Expenses59.0M87.8M140.9M173.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.3M-37.9M-96.9M-158.6M
 
 
 
 
 
Extraordinary Charge0.00---934.5K--
 
 
Interest Expense On Debt99.9K101.3K115.7K244.6K
 
 
 
 
 
Other Expenses0.005.3M9.6M36.1M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.2M-32.5M-88.0M-121.8M
 
 
 
 
 
Income Taxes-9.1M-8.2M-19.3M-31.8M
 
 
 
 
 
Net Income-7.1M-24.4M-68.7M-90.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS--17.5M20.5M--
 
 
 
Shares To Calculate EPS Diluted--17.5M20.5M--
 
 
 
 
Earnings Per ShareEPS---$1.40-$3.35-$3.99
 
 
 
 
EPS Diluted---$1.40-$3.35-$3.99